Strive Asset Management (ASST) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
19 Mar, 2026Executive summary
Accumulated 13,628 bitcoin as of March 17, 2026, through PIPE proceeds, exchange, acquisition, and capital markets activity.
Achieved Bitcoin Yield of 22.2% in Q4 2025 and 13.8% QTD in Q1 2026.
Completed acquisition of Semler Scientific, integrating its 5,048 bitcoin and launching Clinivanta for preventative healthcare.
Raised significant capital via SATA Stock offerings and invested $50 million in STRC Stock.
Financial highlights
GAAP net loss of $393.6 million from September 12 to December 31, 2025; $194.5 million due to fair value decrease in bitcoin holdings.
Non-GAAP adjusted net loss attributable to common stockholders of $208.2 million, or $4.73 per diluted share, with 93.4% from bitcoin fair value decrease.
Cash and cash equivalents totaled $83.7 million as of March 17, 2026.
Bitcoin $ Gain of $114.3 million in Q4 2025 and $78.2 million QTD in Q1 2026.
Outlook and guidance
Focused on building a track record for SATA, maintaining a stable trading range, and a strong balance sheet to generate long-term returns above the Bitcoin hurdle rate.
Sees a multi-trillion dollar opportunity for digital credit to scale in coming years.
Latest events from Strive Asset Management
- Ratification of KPMG LLP as auditor for 2026 is up for shareholder vote.ASST
Proxy Filing16 Mar 2026 - Shareholders will vote virtually on ratifying KPMG LLP as auditor, with board support.ASST
Proxy Filing16 Mar 2026 - Raised $762.6M, held 7,525 bitcoin, and posted a $192.3M net loss, mainly non-cash.ASST
Q3 20259 Feb 2026 - 914,832 shares of Class B Common Stock registered for resale, with no proceeds to the company.ASST
Registration Filing9 Feb 2026 - Resale registration of 467,489 shares may cause significant dilution and price volatility.ASST
Registration Filing9 Feb 2026 - Resale of 7.75M shares may cause significant dilution and volatility, with limited company proceeds.ASST
Registration Filing9 Feb 2026 - Registering 416,694 shares for resale, with high dilution risk and over 90% insider control.ASST
Registration Filing9 Feb 2026 - Registering 1.48M shares for resale, with dilution and control risks for public investors.ASST
Registration Filing9 Feb 2026 - Registering 2.4M shares for resale, with dilution risk and no proceeds to the company.ASST
Registration Filing9 Feb 2026